Authors:
Bobkova, MR
Detkova, NV
Buravtsova, EV
Bondarenko, VO
Bobkov, AF
Pokrovsky, VV
Taylor, GP
Citation: Mr. Bobkova et al., Low prevalence of HTLV-I/II infection among HIV-1-infected injecting drug users in Russia, J ACQ IMM D, 21(4), 1999, pp. 354-354
Authors:
Taylor, GP
Lyall, EGH
Mercey, D
Smith, R
Chester, T
Newell, ML
Tudor-Williams, G
Citation: Gp. Taylor et al., British HIVAssociation guidelines for prescribing antiretroviral therapy in pregnancy (1998), SEX TRANS I, 75(2), 1999, pp. 90-97
Authors:
Taylor, GP
Lyall, EGH
Tudor-Williams, G
Regan, L
Smith, J
Citation: Gp. Taylor et al., Labour care of women with HIV infection - Article did not highlight current guidelines, BR MED J, 319(7206), 1999, pp. 381-382
Citation: Gp. Taylor, Abstracts from the 4th European HTLV Pathogenesis Meeting - Paris, France 9 June, 1999 - Introduction, VIRUS RES, 65(1), 1999, pp. 1-1
Authors:
Clarke, JR
Braganza, R
Mirza, A
Stainsby, C
Ait-Khaled, M
Wright, A
Lyall, H
Parker, D
McClure, MO
Weber, JN
Taylor, GP
Citation: Jr. Clarke et al., Rapid development of genotypic resistance to lamivudine when combined withzidovudine in pregnancy, J MED VIROL, 59(3), 1999, pp. 364-368
Authors:
Jeffery, KJM
Usuku, K
Hall, SE
Matsumoto, W
Taylor, GP
Procter, J
Bunce, M
Ogg, GS
Welsh, KI
Weber, JN
Lloyd, AL
Nowak, MA
Nagai, M
Kodama, D
Izumo, S
Osame, M
Bangham, CRM
Citation: Kjm. Jeffery et al., HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy, P NAS US, 96(7), 1999, pp. 3848-3853
Authors:
Taylor, GP
Hall, SE
Navarrete, S
Michie, CA
Davis, R
Witkover, AD
Rossor, M
Nowak, MA
Rudge, P
Matutes, E
Bangham, CRM
Weber, JN
Citation: Gp. Taylor et al., Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy, J VIROLOGY, 73(12), 1999, pp. 10289-10295